Agency & Consultancy · B2B SaaS Provider · vs · Data Provider / Broker
TransPerfect vs Veeva
Structured technology and market comparison · 2026
Direct Feature Comparison
TransPerfect · vs · VeevaEnterprise localisation software and multilingual business services provider.
Life sciences cloud software and data platform provider.
Analyze all overlapping signals and tech stacks for TransPerfect and Veeva
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between TransPerfect and Veeva?
When comparing TransPerfect and Veeva, both platforms operate within the Agency & Consultancy · B2B SaaS Provider and Data Provider / Broker ecosystem. TransPerfect is positioned as Enterprise localisation software and multilingual business services provider, whereas Veeva focuses on Life sciences cloud software and data platform provider. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to TransPerfect and Veeva?
When evaluating TransPerfect and Veeva, enterprise buyers also consider other platforms in Agency & Consultancy · B2B SaaS Provider and Data Provider / Broker. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of TransPerfect and Veeva compare?
TransPerfect is headquartered in United States (founded in 1992) with 1,001–5,000 employees. Veeva is based in United States (founded in 2007) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: TransPerfect vs Veeva
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
TransPerfect
Recent Signals
No recent market signals documented for TransPerfect in the current tracking window.
Veeva
Recent Signals
- ·PR Newswire: Advertising & MarketingLeadership
Omnicom Appoints Tom Schwenger CEO of Health Marketing
Omnicom (NYSE: OMC) has appointed Tom Schwenger as Chief Executive Officer of Omnicom Health's marketing business, effective immediately. Schwenger, who brings over 35 years of experience in pharma, biotech, and healthcare, will oversee the group's global marketing agencies. He succeeds Dana Maiman, who is leaving the company. Schwenger will work with Michael Larson, who remains Chairman of Omnicom Health and will also oversee the specialty health business. The appointment aims to drive accelerated growth, innovation, and AI adoption for clients amid rapid healthcare market evolution. Schwenger joins from Veeva Systems, where he served as President and Chief Customer Officer and tripled revenue. Previously, he spent nearly three decades at Accenture, leading its life sciences practice.
- Omnicom appointed Tom Schwenger as CEO of Omnicom Health's marketing business.
- Tom Schwenger previously served as President and Chief Customer Officer at Veeva Systems.
- Dana Maiman is leaving Omnicom Health after leading the unit.
- ·PR Newswire: Advertising & MarketingAI in Life Sciences Marketing
Veeva Summit to Showcase Agentic AI and Data Innovations
Veeva Systems announced that leaders from AstraZeneca, Bristol Myers Squibb, Grünenthal, Novo, Roche, UCB, and other biopharma companies will present new strategies for commercial and medical excellence at the Veeva Commercial Summit, Europe, scheduled for November 18-19, 2026, in Copenhagen. The summit will showcase how industry-specific AI enables sales, marketing, and medical teams to improve customer engagement, derive insights, and accelerate compliant content delivery. Key topics include agentic customer engagement, agentic CRM, agentic MLR for content approvals, and building a data foundation for AI with HCP access data and trusted data platforms. The event will feature over 100 sessions and 1,200+ industry experts, highlighting innovations with Veeva's Commercial Cloud and Data Cloud.
- Veeva Commercial Summit Europe is scheduled for November 18-19, 2026, in Copenhagen.
- The summit will feature over 100 sessions and 1,200+ industry experts.
- AstraZeneca, Bristol Myers Squibb, Grünenthal, Novo, Roche, and UCB will present case studies.
- ·PR Newswire: Technology NewsPartnership
IQVIA Expands Veeva Partnership with Clinical Operations Applications
IQVIA and Veeva Systems announced an expansion of their partnership, with IQVIA selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications for its clinical development studies. This extends the previously announced EDC partnership. The collaboration aims to increase trial speed and efficiency, strengthen site centricity, and improve decision-making for clinical research customers. All Veeva clinical solutions will also be available through IQVIA for sponsors seeking a full Veeva technology stack. Executives from both companies emphasized the benefits of integrated technologies and customer flexibility in choosing EDC, RTSM, and eCOA solutions. The announcement was made on October 13, 2026, ahead of the Veeva R&D and Quality Summit scheduled for October 20-21 in Boston.
- IQVIA selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications.
- Partnership expansion extends the previously announced EDC partnership.
- All Veeva clinical solutions will be available through IQVIA for sponsors.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners TransPerfect and Veeva share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks